Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8126 items from SEC EDGAR · clear filters

  • SEC EDGAR•filings
    8-K - Toast, Inc. (0001650164) (Filer)

    Toast, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors and officers, and disclosed compensatory arrangements for the appointed officers.

  • SEC EDGAR•filings
    8-K - Brightline Interactive, Inc./NV (0001854445) (Filer)

    Brightline Interactive, Inc. filed a Form 8-K on October 1, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Valion Bio, Inc. (0001787740) (Filer)

    Valion Bio, Inc. filed a Form 8-K on October 1, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Vylor Inc. (0002128626) (Filer)

    Vylor Inc. filed a Form 8-K on October 1 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Corteva, Inc. (0001755672) (Filer)

    Corteva, Inc. filed a Form 8-K on October 1, 2026, covering Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits); the filing (accession 0001193125-26-409840) is 223 KB.

  • SEC EDGAR•filings
    8-K - EIDP, Inc. (0000030554) (Filer)

    EIDP, Inc. filed a Form 8-K on October 1, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)

    Monte Rosa Therapeutics, Inc. filed a Form 8-K on October 1 2026 (Accession No. 0001193125-26-409833), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Installed Building Products, Inc. (0001580905) (Filer)

    Installed Building Products, Inc. filed a Form 8-K on October 1, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - MCCORMICK & CO INC (0000063754) (Filer)

    Mccormick & Co. filed a Form 8-K on October 1, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CHESAPEAKE UTILITIES CORP (0000019745) (Filer)

    Chesapeake Utilities Corp filed a Form 8-K on October 1, 2026 reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - KYNTRA BIO, INC. (0000921299) (Filer)

    Kyntra Bio, Inc. filed a Form 8-K on October 1, 2026 reporting the departure or appointment of certain officers and directors and disclosing related compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - FrontView REIT, Inc. (0001988494) (Filer)

    FrontView REIT, Inc. filed a Form 8-K on October 1, 2026, containing a Regulation FD disclosure (Item 7.01) and financial statements with related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - CIVISTA BANCSHARES, INC. (0000944745) (Filer)

    Civista Bancshares, Inc. filed a Form 8-K on October 1, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - ACUITY INC. (DE) (0001144215) (Filer)

    Acuity Inc. filed a Form 8-K on October 1, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Slam Corp. (0001838162) (Filer)

    Slam Corp. filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, changes to directors and officers, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Keurig Dr Pepper Inc. (0001418135) (Filer)

    Keurig Dr Pepper Inc. filed a Form 8-K with the SEC on October 1, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - KIMBERLY CLARK CORP (0000055785) (Filer)

    Kimberly Clark Corp filed a Form 8-K reporting the departure of certain directors or officers, the election and appointment of directors and officers, and the related compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - Fervo Energy Co (0001853868) (Filer)

    Fervo Energy Co. filed a Form 8-K on October 1, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Ovintiv Inc. (0001792580) (Filer)

    Ovintiv Inc. filed a Form 8-K on October 1, 2026, containing a Regulation FD disclosure and accompanying financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - D-Wave Quantum Inc. (0001907982) (Filer)

    D-Wave Quantum Inc. filed a Form 8-K on October 1, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Foghorn Therapeutics Inc. (0001822462) (Filer)

    Foghorn Therapeutics filed a Form 8-K on October 1, 2026, including disclosures on costs associated with exit or disposal activities, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sadot Group Inc. (0001701756) (Filer)

    Sadot Group Inc. filed a Form 8-K reporting a material definitive agreement, completion of an acquisition, unregistered equity sales, modifications to security holder rights, amendments to its charter and fiscal year, and accompanying financial statements.

  • SEC EDGAR•filings
    8-K - INNOVATIVE INDUSTRIAL PROPERTIES INC (0001677576) (Filer)

    Innovative Industrial Properties Inc filed a Form 8-K on Oct. 1, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - VerifyMe, Inc. (0001104038) (Filer)

    VerifyMe, Inc. filed a Form 8-K with the SEC on October 1, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - NATIONAL FUEL GAS CO (0000070145) (Filer)

    National Fuel Gas Co filed an 8-K reporting a material definitive agreement, completion of an asset acquisition/disposition, creation of a direct financial obligation/off-balance-sheet arrangement, a Regulation FD disclosure, and related financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CARDINAL HEALTH INC (0000721371) (Filer)

    Cardinal Health Inc. filed a Form 8-K on October 1, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - CENTERPOINT ENERGY RESOURCES CORP (0001042773) (Filer)

    Centerpoint Energy Resources Corp filed a Form 8-K on October 1, 2026, reporting completion of an acquisition or disposition of assets, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CENTERPOINT ENERGY INC (0001130310) (Filer)

    CenterPoint Energy Inc filed a Form 8-K on October 1, 2026, reporting the completion of an acquisition or disposition of assets, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - AMERICAN VANGUARD CORP (0000005981) (Filer)

    American Vanguard Corp filed a Form 8-K on Oct. 1, 2026 reporting director/officer departures and appointments, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Accenture plc (0001467373) (Filer)

    Accenture plc filed a Form 8-K on October 1, 2026, including Item 2.02 detailing its results of operations and financial condition, and Item 9.01 providing its financial statements and related exhibits.